Texas Chapter of AACE (TX-AACE) Annual Meeting / Texas Endocrine Surgical Society (TESS) Surgical Symposium
Target Audience
Endocrinologists, endocrine surgeons, and other health care professionals living in Texas who practice, or are interested in, the treatment of endocrine disease states.
Learning Objectives
- After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices
- Understand the cardiovascular effects from GLP1 & SGLT2 trials
- Risk and benefits of these new cardiovascular agents in diabetes
- Understand yearly event rate in diabetes of new trials
- Define type 2 diabetes remission
- Analyze the evidence base in support of remission of type 2 diabetes and understand a systematic approach to studying it
- Differentiate diabetes remission and prevention
- Increase awareness on the role of insulin resistance, diabetes and ethnicity to the development of non-alcoholic fatty liver disease
- Understand dilemmas that the endocrinologist faces in the diagnosis and management of such patients
- Review the choices and expected benefits of current treatments for non-alcoholic fatty liver disease
- Define the orderly workup and differential diagnosis for fasting hypoglycemia
- Identify the clinical and pathologic features of adult nesidioblastosis
- Identify indications for work up of hypoglycemia
- Recognize obscure causes of hypoglycemia in a diabetic patient
- Recognize the essential elements of the diagnostic workup to establish the presence of surgically correctable (endogenous) hyperinsulinism
- Understand the current role of preoperative imaging tests for patients with insulinoma
- Describe the current surgical approach and strategy for resection of solitary insulinoma, noninsulinoma pancreatogenous hypoglycemia, and adult nesidioblastosis
- Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
- Describe the investigations and differential diagnosis of hyperaldosteronism
- Interpret the results of adrenal vein sampling in patients with hyperaldosteronism
- Describe the medical and surgical management of hyperaldosteronism
- Discuss the optimal surgical approaches for management of patients with adrenal cortical carcinoma
- Summarize the potential indications for adjuvant and neoadjuvant systemic treatment of adrenal cortical carcinoma
- Describe current and potential future systemic treatment options for patients with advanced adrenal cortical carcinoma
- Recognize the prevalence of persistent and recurrent disease following surgical remission of Cushing’s disease and acromegaly
- Debate the patient specific characteristics which could be appropriate for treatment with mifepristone or pasireotide
- Discuss indications for mifepristone, pasireotide, in the treatment of Cushing’s syndrome and acromegaly
- At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
- After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
- Describe a central node dissection and differentiate a therapeutic and prophylactic central neck dissection
- Define the role of central node dissection in the management of papillary thyroid cancer
- Review the controversy surrounding prophylactic central node dissection in patients with clinically node negative disease
- Describe the genotype-phenotype relationships of various RET protooncogene mutations in children with MEN2
- Understand the basis for current recommendations of timing of early thyroidectomy based on mutation risk stratification
- Understand the current controversies regarding extent of cervical lymphadenectomy and management of the parathyroid glands in children undergoing early thyroidectomy for MEN2
- Identify causes of enlarged extraocular muscles that can mimic Graves ophthalmopathy
- Explain the role of corticosteroids in the treatment of Graves ophthalmopathy
- Summarize the individualized approach to medical and surgical treatment of Graves ophthalmopathy to optimize results
- Review the anatomy of the recurrent laryngeal nerve and its association with the ligament of berry and tubercle of zuckerkandl, injury rates and implications
- Discuss management of the tubercle of zuckerkandl during thyroid surgery
- Implications of inadequate management of the tubercle of zuckerkandl/ligament of berry for the endocrinologist
- Allow the audience to further explore and clarify issues related to the morning's presentations with the faculty
- Determine which patients with low bone density require treatment, along with optimal duration of treatment
- Select antiresorptive agents based on the patient's individual characteristics and preferences
- Recognize the benefits of anabolic agents in specific subpopulations of osteoporosis patients
- 4D-CT evaluation of hyperparathyroidism
- Ultrasound characteristics of parathyroid adenomas vs. lymph nodes
- Intraoperative support for minimally invasive parathyroidectomy and localization of transplanted parathyroid tissue
- Understand the etiologies of hypoparathyroidism
- Discuss the medical treatment of hypoparathyroidism
- Understand the use of parathyroid hormone in hypoparathyroidism
- Through fellow presentations, allow the audience to learn and participate in the evaluation of usual medical cases.
- At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Friday, August 4, 2017 | ||
7:00 - 8:00 AM | Continental Breakfast | |
8:00 - 8:30 AM | Welcoming Remarks & Pre Meeting Assessment Objectives:
| |
SESSION 1 - | DIABETES | METABOLIC SECTION | |
8:30 - 9:05 AM | A Cardiovascular Diagnosis & GLP1/SGLT2 Robert Chilton, DO, FACC Objectives:
| |
9:05 - 9:40 AM | Systematically Assessing the Promise of Diabetes Remission Hertzel C. Gerstein, MD, MSc, FRCPC Objectives:
| |
9:40 - 10:15 AM | Metabolic Insights into Non-Alcoholic Fatty Liver Disease: The overlooked complication of type 2 diabetes Kenneth Cusi, MD, FACP, FACE Objectives:
| |
10:15 - 10:45 AM | Break | |
10:45 - 11:20 AM | Interesting Cases Fasting Hypoglycemia in a Previously Healthy Nurse Henry Reinhart, MD Objectives:
| |
An Unusual Cause of Hypoglycemia Stacey Milan, MD, FACS Objectives:
| ||
11:20 - 11:55 AM | Surgical Management of Endogenous Hyperinsulinism Terry C. Lairmore, MD, FACS Objectives:
| |
11:55 - 12:15 PM | Diabetes / Metabolic Panel Discussion Robert Chilton, DO, FACC; Hertzel C. Gerstein, MD, MSc, FRCPC; Kenneth Cusi, MD, FACP, FACE; Terry C. Lairmore, MD, FACS Objectives:
| |
12:30 - 2:00 PM | Lunch | |
SESSION 2 - | ADRENAL | PITUITARY | NEUROENDOCRINE SECTION | |
2:00 - 2:35 PM | Controversies in the Management of Primary Hyperaldosteronism Alan Dackiw, MD, PhD, MBA, FACS Objectives:
| |
2:35 - 3:05 PM | Current Management of Adrenal Cortical Carcinoma Jeffrey E. Lee, MD Objectives:
| |
3:05 - 3:40 PM | Break | |
3:40 - 4:15 PM | Challenging Pituitary Cases Thomas Blevins, MD, FNLA, FACE, ECNU; Sue Samson, MD, PhD, FRCPC, FACE Objectives:
| |
4:15 - 4:45 PM | Post Meeting Assessment Objectives:
| |
4:45 - 5:30 PM | TX-AACE Chapter Business Meeting / Reception | |
Saturday, August 5, 2017 | ||
6:45 - 7:40 AM | Continental Breakfast | |
7:40 - 8:05 AM | Welcoming Remarks & Pre Meeting Assessment Objectives:
| |
SESSION 3 – | THYROID SECTION | |
8:05 - 9:05 AM | Pros / Cons Central Lymph Node Dissection There is no role for Prophylactic Central Compartment Neck Dissection Christopher McHenry, MD | |
Routine Central Lymph Node Dissection Should be Performed in Patients with Papillary Thyroid Cancer Samuel Snyder, MD, FACS Objectives:
Meets CME requirements for ECNU recertification | ||
9:05 - 9:40 AM | Timing of Early Preventative Thyroidectomy in Children with MEN 2 Terry C. Lairmore, MD, FACS Objectives:
| |
9:40 - 10:10 AM | Break | |
10:10 - 10:45 AM | Graves Ophthalmopathy: Advances in diagnosis and treatment Constance Fry, MD Objectives:
| |
10:45 - 11:20 AM | Management of the Recurrent Laryngeal Nerve at the Ligament of Berry: Implications for the endocrinologist and surgeon Nathan Hales, MD, FACS Objectives:
| |
11:20 - 11:55 AM | Thyroid Panel Discussion Christopher McHenry, MD; Samuel Snyder, MD, FACS; Terry C. Lairmore, MD, FACS; Constance Fry, MD; Nathan Hales, MD, FACS Objectives:
| |
11:55 - 1:30 PM | Lunch | |
SESSION 4 – | BONE SECTION | |
1:30 - 2:15 PM | Osteoporosis & Drug Classes – A Case-based Discussion Laila Tabatabai, MD Objectives:
| |
2:15 - 2:45 PM | Parathyroid Imaging: Current concepts Maria Gule-Monroe, MD Objectives:
| |
2:45 - 3:20 PM | Hypoparathyroidism - A Case-based Discussion Mimi Hu, MD Objectives:
| |
3:20 - 3:55 PM 3:20-3:35 3:35-3:50 3:50-3:55 | Interesting Cases Real Pregnancy or Uncontrolled Hypothyroidism? Christie G. Turin, MD An Adult with a Very Low Alkaline Phosphatase Thomas Blevins, MD, FNLA, FACE, ECNU Q & A Objectives:
| |
3:55 - 4:30 PM | Post Meeting Assessment / Adjourn Objectives:
|
Thomas Blevins, MD, FNLA, FACE, ECNU
Texas Diabetes and Endocrinology, PA
Austin, TX
Robert J. Chilton, DO, FACC
Associate Professor
Department of Medicine, Division of Cardiology
The University of Texas Health Science Center at San Antonio
San Antonio, TX
Kenneth Cusi, MD, FACP, FACE
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
University of Florida
School of Medicine
Gainesville, FL
Alan Dackiw, MD, PhD, MBA, FACS
Professor of Surgery
University of Texas Southwestern Medical Center
Dallas, TX
Constance Fry, MD
Associate Professor of Ophthalmology
Chief of Ophthalmic Plastic Surgery & Ophthalmic Oncology
The University of Texas Health Science Center at San Antonio
San Antonio, TX
Hertzel Gerstein, MD, MSc, FRCPC
Professor of Medicine,
Director, Division of Endocrinology & Metabolism
Population Health Research Institute Chair in Diabetes
McMaster University
Hamilton, Ontario, Canada
Maria Gule-Monroe, MD
Assistant Professor -Diagnostic Radiology
Neuroradiology Section
The University of Texas
MD Anderson Cancer Center
Houston, TX
Nathan W. Hales, MD, FACS
Associate Professor
Uniformed Services University of the Health Sciences, Civilian
Otolaryngology, Head and Neck Surgical Oncology
Thyroid and Parathyroid Surgery
San Antonio Head and Neck
San Antonio, TX
Mimi Hu, MD
Associate Professor
Department of Endocrine Neoplasia and Hormonal Disorders
University of Texas M. D. Anderson Cancer Center
Houston, TX
Terry C. Lairmore, MD, FACS
Professor of Surgery
Director, Division of Surgical Oncology
Baylor Scott & White Health
Texas A&M University Health Science Center
Temple, TX
Jeffrey E. Lee, MD
Professor and Chair, Department of Surgical Oncology
Irving and Nadine Mansfield and Robert David Levitt Cancer Research Chair
The University of Texas MD Anderson Cancer Center
Houston, TX
Christopher R. McHenry
Vice Chairman Department of Surgery
MetroHealth Medical Center
Professor of Surgery
Case Western Reserve University School of Medicine
Cleveland, OH
Stacey Milan, MD, FACS
Assistant Professor of Surgery
Baylor Scott & White Hospital
Temple, TX
Henry A. Reinhart, MD
Assistant Professor of Surgery
University of Texas Rio Grande Valley School of Medicine
Edinburg, TX
Susan Samson, MD, PhD, FRCPC, FACE
Associate Professor of Medicine
Baylor College of Medicine
Medical Director, The Pituitary Center at Baylor St. Luke's Medical Center
Endocrinology Fellowship Director
Houston, TX
Samuel K. Snyder, MD, FACS
Vice-Chairman, Department of Surgery
Chief, Section of Endocrine Surgery
Baylor Scott & White Health
Texas A&M University Health Science Center
Temple, TX
Laila S. Tabatabai, MD
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Adjunct Assistant Professor of Internal Medicine, Texas A&M University, College of Medicine
Division of Endocrinology, Diabetes & Metabolism
Houston Methodist Hospital
Houston, TX
Christie G. Turin More, MD
Internal Medicine Resident
Baylor College of Medicine
Houston, TX
The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 12.75 AMA
- 12.75 Attendance